Ipilimumab vs Plitidepsin

## Ipilimumab vs Plitidepsin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Plitidepsin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Plitidepsin — N/A.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Plitidepsin — Small molecule.